These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1700834)

  • 1. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.
    Werner A; Winskowsky G; Kurth R
    J Virol; 1990 Dec; 64(12):6252-6. PubMed ID: 1700834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation.
    Allan JS; Whitehead EM; Strout K; Short M; Kanda P; Hart TK; Bugelski PJ
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2011-20. PubMed ID: 1493051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian immunodeficiency virus from African green monkeys.
    Daniel MD; Li Y; Naidu YM; Durda PJ; Schmidt DK; Troup CD; Silva DP; MacKey JJ; Kestler HW; Sehgal PK
    J Virol; 1988 Nov; 62(11):4123-8. PubMed ID: 3172340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm.
    Werner A; Winskowsky G; Cichutek K; Norley SG; Kurth R
    AIDS; 1990 Jun; 4(6):537-44. PubMed ID: 1974766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of SIV infection with soluble receptor molecules.
    Allan JS; Strauss J; Buck DW
    Science; 1990 Mar; 247(4946):1084-8. PubMed ID: 2309120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.
    Sutjipto S; Kodama T; Yee J; Gettie A; Jennings M; Desrosiers RC; Marx PA
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():247-9. PubMed ID: 1689369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.
    Ennen J; Findeklee H; Dittmar MT; Norley S; Ernst M; Kurth R
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7207-11. PubMed ID: 7913749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.
    Schenten D; Marcon L; Karlsson GB; Parolin C; Kodama T; Gerard N; Sodroski J
    J Virol; 1999 Jul; 73(7):5373-80. PubMed ID: 10364284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN; Phelan M; Mallinson M; Norcross MA
    J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIVagm: genetic and biological features associated with replication.
    Müller MC; Barré-Sinoussi F
    Front Biosci; 2003 Sep; 8():d1170-85. PubMed ID: 12957815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys.
    Kraus G; Werner A; Baier M; Binniger D; Ferdinand FJ; Norley S; Kurth R
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2892-6. PubMed ID: 2468160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
    J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
    Montefiori DC; Robinson WE; Hirsch VM; Modliszewski A; Mitchell WM; Johnson PR
    J Virol; 1990 Jan; 64(1):113-9. PubMed ID: 2152808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Chackerian B; Haigwood NL; Overbaugh J
    Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
    Clapham PR; Weber JN; Whitby D; McIntosh K; Dalgleish AG; Maddon PJ; Deen KC; Sweet RW; Weiss RA
    Nature; 1989 Jan; 337(6205):368-70. PubMed ID: 2536142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency.
    Otto C; Puffer BA; Pöhlmann S; Doms RW; Kirchhoff F
    Virology; 2003 Oct; 315(2):292-302. PubMed ID: 14585332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.
    Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G
    J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    Moore JP; McKeating JA; Norton WA; Sattentau QJ
    J Virol; 1991 Mar; 65(3):1133-40. PubMed ID: 1995942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1.
    Schutten M; Andeweg AC; Bosch ML; Osterhaus AD
    Scand J Immunol; 1995 Jan; 41(1):18-22. PubMed ID: 7824885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.